253 related articles for article (PubMed ID: 12480669)
1. Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature.
Warnatz K; Peter HH; Schumacher M; Wiese L; Prasse A; Petschner F; Vaith P; Volk B; Weiner SM
Ann Rheum Dis; 2003 Jan; 62(1):50-7. PubMed ID: 12480669
[TBL] [Abstract][Full Text] [Related]
2. [Progressive multifocal leukoencephalopathy and rheumatic disease].
Kneitz C; Wiendl H
Z Rheumatol; 2008 Jul; 67(4):290, 292-4. PubMed ID: 18483740
[TBL] [Abstract][Full Text] [Related]
3. [Progressive multifocal leukoencephalopathy as a result of immunosuppressive therapy].
Arbusow V; Strupp M; Samtleben W; Hatz H; Brückmann H; Brandt T
Dtsch Med Wochenschr; 1999 May; 124(21):653-6. PubMed ID: 10382545
[TBL] [Abstract][Full Text] [Related]
4. The Risk of Progressive Multifocal Leukoencephalopathy in the Biologic Era: Prevention and Management.
Molloy ES; Calabrese CM; Calabrese LH
Rheum Dis Clin North Am; 2017 Feb; 43(1):95-109. PubMed ID: 27890176
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system involvement in pediatric rheumatic diseases: current concepts in treatment.
Duzova A; Bakkaloglu A
Curr Pharm Des; 2008; 14(13):1295-301. PubMed ID: 18537653
[TBL] [Abstract][Full Text] [Related]
6. [A case of progressive multifocal leukoencephalopathy presenting white matter MRI lesions extending over the cerebral cortex and a marked decrease in cerebral blood flow on SPECT, and associated with HTLV-I infection].
Takase K; Ohyagi Y; Furuya H; Nagashima K; Taniwaki T; Kira J
Rinsho Shinkeigaku; 2005 Jun; 45(6):426-30. PubMed ID: 16022467
[TBL] [Abstract][Full Text] [Related]
7. Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies.
Calabrese LH; Molloy ES
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii64-5. PubMed ID: 19022817
[TBL] [Abstract][Full Text] [Related]
8. Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?
Molloy ES; Calabrese LH
Autoimmun Rev; 2008 Dec; 8(2):144-6. PubMed ID: 18700172
[TBL] [Abstract][Full Text] [Related]
9. [Progressive multifocal leukoencephalopathy in a patient following long-term immunosuppressive therapy for systemic lupus erythematosus].
Kappers MH; Swaak AJ; Zuidgeest DM; Dees A
Ned Tijdschr Geneeskd; 2006 Feb; 150(7):387-92. PubMed ID: 16523804
[TBL] [Abstract][Full Text] [Related]
10. Progressive multifocal leukoencephalopathy.
Aksamit AJ
Continuum (Minneap Minn); 2012 Dec; 18(6 Infectious Disease):1374-91. PubMed ID: 23221846
[TBL] [Abstract][Full Text] [Related]
11. Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies.
Molloy ES; Calabrese LH
Arthritis Rheum; 2012 Sep; 64(9):3043-51. PubMed ID: 22422012
[TBL] [Abstract][Full Text] [Related]
12. Progressive multifocal leukoencephalopathy mimicking cerebral vasculitis in systemic granulomatosis.
Terrier B; Martinez V; Seilhean D; Chapelon-Abric C; Vaghefi P; Sanson M; Bricaire F; Piette JC; Caumes E
J Infect; 2007 Mar; 54(3):e133-5. PubMed ID: 17052759
[TBL] [Abstract][Full Text] [Related]
13. [Progressive multifocal leukoencephalopathy in an elderly patient with no obvious immunosuppression].
Coşkun O; Sener K; Turhan V; Ongürü O; Gül HC; Eyigün CP
Mikrobiyol Bul; 2010 Jan; 44(1):141-7. PubMed ID: 20455411
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system systemic lupus erythematosus mimicking progressive multifocal leucoencephalopathy.
Kaye BR; Neuwelt CM; London SS; DeArmond SJ
Ann Rheum Dis; 1992 Oct; 51(10):1152-6. PubMed ID: 1444628
[TBL] [Abstract][Full Text] [Related]
15. Progressive multifocal encephalopathy after cyclophosphamide in granulomatosis with polyangiitis (Wegener) patients: case report and review of literature.
Pugnet G; Pagnoux C; Bézanahary H; Ly KH; Vidal E; Guillevin L
Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S62-4. PubMed ID: 23663683
[TBL] [Abstract][Full Text] [Related]
16. Progressive multifocal leukoencephalopathy complicating treatment for Wegener's granulomatosis.
Morgenstern LB; Pardo CA
J Rheumatol; 1995 Aug; 22(8):1593-5. PubMed ID: 7473491
[TBL] [Abstract][Full Text] [Related]
17. Central Nervous System Infections Associated with Immunosuppressive Therapy for Rheumatic Disease.
Bradshaw MJ; Cho TA; Chow FC
Rheum Dis Clin North Am; 2017 Nov; 43(4):607-619. PubMed ID: 29061246
[TBL] [Abstract][Full Text] [Related]
18. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases.
Boren EJ; Cheema GS; Naguwa SM; Ansari AA; Gershwin ME
J Autoimmun; 2008; 30(1-2):90-8. PubMed ID: 18191544
[TBL] [Abstract][Full Text] [Related]
19. Myelosuppression-sparing treatment of central nervous system nocardiosis in a multiple myeloma patient utilizing a tedizolid-based regimen: a case report.
Matin A; Sharma S; Mathur P; Apewokin SK
Int J Antimicrob Agents; 2017 Apr; 49(4):488-492. PubMed ID: 28189735
[TBL] [Abstract][Full Text] [Related]
20. Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus.
Fang H; Lan L; Qu Y; Zhang Q; Lv J
J Int Med Res; 2018 Jan; 46(1):485-491. PubMed ID: 28823196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
